What is tirzepatide?
It’s a new medication that’s shown a lot of promise in helping people lose weight. It’s marketed (and sold) under the brand name Mounjaro. It’s actually a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This means that it mimics two different hormones in our bodies, affecting our appetite, how we process food and how we manage glucose levels.
Is tirzepatide licensed in the UK?
Yes, it is. Tirzepatide has been approved for use in the UK, but it’s still relatively new on the market. You need a prescription for it, and it’s typically prescribed for people who are either obese, with a BMI of 30 or higher, or overweight with a BMI of 27 or higher and have other weight-related health conditions like high blood pressure.
How does it actually work?
Tirzepatide works by mimicking the effects of GIP and GLP-1 hormones. These hormones help to regulate your appetite and insulin levels. When you take tirzepatide, it helps you feel fuller for longer after eating, which can reduce your overall calorie intake. It also slows down the emptying of your stomach and improves your body’s insulin sensitivity. This combination of effects can lead to significant weight loss over time.
Is tirzepatide a GLP-1?
It’s a bit more complex than that. Tirzepatide is actually a dual agonist, which means it activates both the GIP and GLP-1 receptors. Most other weight loss injections, like semaglutide, only target the GLP-1 receptor. By targeting both, tirzepatide can have a greater effect on weight loss.
How long does it take to work?
Typically, you will start to notice some changes within a few weeks, but more significant weight loss usually becomes apparent over a few months. Clinical studies have shown that people taking tirzepatide can lose a substantial amount of weight over a period of about a year. Of course, individual results can vary, and it’s important to combine the medication with healthy lifestyle changes.